Financhill
Sell
1

STI Quote, Financials, Valuation and Earnings

Last price:
$0.37
Seasonality move :
-32.05%
Day range:
$0.36 - $0.40
52-week range:
$0.27 - $11.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.8M
Avg. volume:
7.2M
1-year change:
-96.11%
Market cap:
$46M
Revenue:
--
EPS (TTM):
-$0.41
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- $10.4K -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $20.9K -- --
Gross Profit -- -- -$10.5K -- --
Gross Profit Margin -- -- -100.68% -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $2.4M $904.2K $3.5M
Other Inc / (Exp) -- -- $9.8K $1.8M -$14.7M
Operating Expenses -- -- $3.5M $904.2K $3.5M
Operating Income -- -- -$3.5M -$904.2K -$3.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -$3.5M $933.8K -$18.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $339.9K $1.6M
Net Income to Company -- -- -$3.5M $593.9K -$19.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$3.5M $593.9K -$19.8M
 
Basic EPS (Cont. Ops) -- -- -$0.05 $0.01 -$0.27
Diluted EPS (Cont. Ops) -- -- -$0.05 $0.01 -$0.27
Weighted Average Basic Share -- -- $69.8M $73.2M $81.9M
Weighted Average Diluted Share -- -- $69.8M $73.2M $81.9M
 
EBITDA -- -- -$2.8M -$904.2K -$3.5M
EBIT -- -- -$3.5M -$904.2K -$3.5M
 
Revenue (Reported) -- -- $10.4K -- --
Operating Income (Reported) -- -- -$3.5M -$904.2K -$3.5M
Operating Income (Adjusted) -- -- -$3.5M -$904.2K -$3.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $1.3K --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- $1.3K --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $872K $459.8K
Selling, General & Admin -- -- -- $567.9K $3.7M
Other Inc / (Exp) -- -- -- $1.1K -$2.4M
Operating Expenses -- -- -- $1.4M $4.2M
Operating Income -- -- -- -$1.4M -$4.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$1.4M -$6.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$1.4M -$6.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$1.4M -$6.6M
 
Basic EPS (Cont. Ops) -- -- -- -$0.02 -$0.07
Diluted EPS (Cont. Ops) -- -- -- -$0.02 -$0.07
Weighted Average Basic Share -- -- -- $69.8M $99.5M
Weighted Average Diluted Share -- -- -- $69.8M $99.5M
 
EBITDA -- -- -- -$1.2M -$6.5M
EBIT -- -- -- -$1.4M -$6.6M
 
Revenue (Reported) -- -- -- $1.3K --
Operating Income (Reported) -- -- -- -$1.4M -$4.2M
Operating Income (Adjusted) -- -- -- -$1.4M -$6.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- $10.9M
Other Inc / (Exp) -- -- -- $1.8K -$18.2M
Operating Expenses -- -- -- -- $10.2M
Operating Income -- -- -- -- -$10.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- -$28.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- -$29.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- -$29.9M
 
Basic EPS (Cont. Ops) -- -- -- -- -$0.41
Diluted EPS (Cont. Ops) -- -- -- -- -$0.41
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- -$13.3M
EBIT -- -- -- -- -$13.6M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- -$10.2M
Operating Income (Adjusted) -- -- -- -- -$13.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $1.6K --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- $1.6K --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $2.3M $1.6M
Selling, General & Admin -- -- -- $1.9M $9.3M
Other Inc / (Exp) -- -- -- $1.8K -$3.5M
Operating Expenses -- -- -- $4.2M $10.9M
Operating Income -- -- -- -$4.2M -$10.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$4.2M -$14.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$4.2M -$14.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$4.2M -$14.4M
 
Basic EPS (Cont. Ops) -- -- -- -$0.05 -$0.20
Diluted EPS (Cont. Ops) -- -- -- -$0.05 -$0.20
Weighted Average Basic Share -- -- -- $212.8M $264.6M
Weighted Average Diluted Share -- -- -- $212.8M $273.8M
 
EBITDA -- -- -- -$3.8M -$14M
EBIT -- -- -- -$4.2M -$14.3M
 
Revenue (Reported) -- -- -- $1.6K --
Operating Income (Reported) -- -- -- -$4.2M -$10.9M
Operating Income (Adjusted) -- -- -- -$4.2M -$14.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- $8.7K $545.7K $20K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- $1K -- --
Inventory -- -- $22.7K -- --
Prepaid Expenses -- -- $44.7K $215.6K $85.5K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- $1.3M $761.3K $28.4M
 
Property Plant And Equipment -- -- $3.2M -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- $1.2M -- --
Other Long-Term Assets -- -- -- $127.8M $43M
Total Assets -- -- $6.7M $128.6M $71.3M
 
Accounts Payable -- -- $380 $439.1K $2.1M
Accrued Expenses -- -- $23.4K $5K --
Current Portion Of Long-Term Debt -- -- -- $125.3K $2.2M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- $64.6M
Total Current Liabilities -- -- $23.7K $909.3K $71.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $23.7K $132.5M $99.9M
 
Common Stock -- -- -- $320 $320
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- $6.7M -$3.9M -$28.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- $6.7M -$3.9M -$28.5M
 
Total Liabilities and Equity -- -- $6.7M $128.6M $71.3M
Cash and Short Terms -- -- $8.7K $545.7K $20K
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $1.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- $1K
Inventory -- -- -- -- $24.4K
Prepaid Expenses -- -- -- -- $163.8K
Other Current Assets -- -- -- -- $356.3K
Total Current Assets -- -- -- -- $2M
 
Property Plant And Equipment -- -- -- -- $2.1M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- $1.9M
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- $6.1M
 
Accounts Payable -- -- -- -- $2.1M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- $527.5K
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- $19.3M
Total Current Liabilities -- -- -- -- $24.9M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $24.9M
 
Common Stock -- -- -- -- $11.7K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- -$18.8M
 
Total Liabilities and Equity -- -- -- -- $6.1M
Cash and Short Terms -- -- -- -- $1.2M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -$3.5M $593.9K -$19.8M
Depreciation & Amoritzation -- -- $657.2K -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- $32.7K -- --
Change in Inventories -- -- $19.4K -- --
Cash From Operations -- -- -$2.8M -$725.1K -$2.7M
 
Capital Expenditures -- -- $261.5K -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$261.5K -$126M $88.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $2.1M
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- -$89M
Other Financing Activities -- -- $3.1M -$1.7M $520K
Cash From Financing -- -- $3.1M $127.2M -$86.4M
 
Beginning Cash (CF) -- -- $43K -- $545.7K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$34.3K $545.7K -$525.7K
Ending Cash (CF) -- -- $8.7K $545.7K $20K
 
Levered Free Cash Flow -- -- -$3.1M -$725.1K -$2.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$1.4M -$6.6M
Depreciation & Amoritzation -- -- -- $274.5K $101.5K
Stock-Based Compensation -- -- -- -- $278.2K
Change in Accounts Receivable -- -- -- -$187.6K --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$1.1M -$2.1M
 
Capital Expenditures -- -- -- $239.3K --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$239.3K -$33.1K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- -$905.4K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$157.4K
Cash From Financing -- -- -- $1.4M $3.1M
 
Beginning Cash (CF) -- -- -- $1K $256.5K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $910 $932.2K
Ending Cash (CF) -- -- -- $2K $1.2M
 
Levered Free Cash Flow -- -- -- -$1.4M -$2.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- -$29.9M
Depreciation & Amoritzation -- -- -- -- -$157.9K
Stock-Based Compensation -- -- -- -- $2.1M
Change in Accounts Receivable -- -- -- -- $73.7K
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$5M
 
Capital Expenditures -- -- -- $301.5K --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- $88.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $3.3M
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- -$82.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $1.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$4.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$4.2M -$14.4M
Depreciation & Amoritzation -- -- -- $456.7K $298.8K
Stock-Based Compensation -- -- -- -- $2.1M
Change in Accounts Receivable -- -- -- -$187.6K -$113.8K
Change in Inventories -- -- -- -- -$1.7K
Cash From Operations -- -- -- -$3.3M -$5.7M
 
Capital Expenditures -- -- -- $301.6K --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$301.5K -$190.9K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $1.2M
Long-Term Debt Repaid -- -- -- -- -$1.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$1.3M
Cash From Financing -- -- -- $3M $7.1M
 
Beginning Cash (CF) -- -- -- $643K $2.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$619.6K $1.2M
Ending Cash (CF) -- -- -- $23.4K $3.3M
 
Levered Free Cash Flow -- -- -- -$3.6M -$5.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock